News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LeMaitre Vascular, Inc. Q3 2012 Sales $13.65mm (+5% Organic), Op. Profit $1.0mm



10/31/2012 7:06:01 AM

BURLINGTON, Mass., Oct. 30, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2012 sales of $13.65mm and operating profit of $1.0mm. Recently, the Company has also announced three new strategic initiatives: the XenoSure acquisition, the opening of a Canadian office and Switzerland direct. The Company also approved a quarterly cash dividend of $0.025 per share, and provided Q4 2012 guidance.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES